Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GSK2879552 |
Synonyms | |
Therapy Description |
GSK2879552 binds to and inhibits lysine specific demethylase 1 (LSD1, KDM1A), thereby suppressing tumor cell proliferation (PMID: 26175415, PMID: 31801559). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GSK2879552 | GSK-2879552|GSK 2879552 | GSK2879552 binds to and inhibits lysine specific demethylase 1 (LSD1, KDM1A), thereby suppressing tumor cell proliferation (PMID: 26175415, PMID: 31801559). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02177812 | Phase I | GSK2879552 | A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML) | Terminated | USA | CAN | AUS | 0 |
NCT02034123 | Phase I | GSK2879552 | Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma | Terminated | USA | FRA | ESP | 0 |